Journal of Clinical Endocrinology & Metabolism

Article	Citations
Correction to “Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments”	772
Correction to: “Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM”	511
Response to Letter to the Editor From Jagannath and Mayilvaganan: “FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography”	285
Response to Letter to the Editor From de Zegher and Ibáñez: “Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis”	178
Correction to: “Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism”	130
Response to Letter to the Editor From Sukor and Kamaruddin: “Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation”	127
Anti-Androgen and Aromatase Inhibitor Do Not Enhance Height in Children With CAH	112
Signs of Potential Androgen Excess Across the Lifespan in a US-based Digital Cohort Study	111
Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia	110
Correction to: “Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study”	102
Response to Letter to the Editor From Hasebe and Su: “Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion”	94
Correction to: “Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication”	92
Correction to: “Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults”	91
Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes	88
Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”	88
Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study	88
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents	86
Correction to: “Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline”	84
Type 2 Diabetes Remission: Achieving Calorie Restriction and Weight Loss by Any Which Way?	82
Approach to the Patient: Type 1 Diabetes Management With Exercise—Prepare, Perform, Stabilize, and Study	82
Initial Evaluation of Radioiodine Therapy Using Imaging for Long-term Prognosis in Thyroid Cancer: A Retrospective Study	77
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?	76
Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle	75
Tirzepatide Heralds the Hope of Chronic Disease Eradication	75
Effects of Maternal Exercise Modes on Glucose and Lipid Metabolism in Offspring Stem Cells	75

Circulating plasma follistatin follows a 24-hour rhythm in healthy young males	74
Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth	74
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia	72
Growth Patterns of Children With Short Stature in Adulthood According to Auxological Status and Maturity at Birth	69
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study	68
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12	67
Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis	67
Sex Steroids and Women’s Physical Performance in Midlife: Findings From the Menarche-To-PreMenopause Study	67
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women—A J-shaped Relationship	66
Approach to the Patient With Primary Aldosteronism: Role of Molecular Imaging	65
Correction to: “Critical Approach to Hypothyroid Patients With Persistent Symptoms”	64
The dynamic adrenal response of children to cardiac surgery and cardiac catheterization	64
Tracking and Cumulative Lifetime Exposure to IGF-I in 6459 Healthy Individuals and in SGA Children Treated With GH	63
Impact of recurrent hypoglycemia on brain glucose transport kinetics in type 1 diabetes	62
New Treatments for Acromegaly in Development	62
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)	61
Blood Plasma Proteome-Wide Association Study Implicates New Proteins in Type 2 Diabetes Mellitus Pathogenesis	61
A Review of Hot Flash Management in Patients With Prostate Cancer	60
Characterizing 24-Hour Skeletal Muscle Gene Expression Alongside Metabolic and Endocrine Responses Under Diurnal Conditions	60
Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition	57
Association Between Urinary Phthalate Metabolites and Sarcopenia in US Adults From NHANES 2011-2018	57
Insights on Improving Health Insurance Literacy in Diabetes	57
Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency In Pregnant Women	55
Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis	54
Severity of MASH activity by iron-corrected MRI predicts insulin resistance and cardiometabolic risk in type 2 diabetes	54
A Step Toward Disentangling the Complex Relationship Between Vitamin D and Kidney Function	52
The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study	51
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study	51
Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci	51
Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index	51
Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review	51
Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2003-2004, 2011-2012	50
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes	49
Cognitive Function in Individuals with Chronic Hypoparathyroidism—A Prospective Observational Study	48
Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population	48
Prospective Multicenter Registry–Based Study on Thyroid Storm: The Guidelines for Management From Japan Are Useful	48
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease	48
The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors	48
Mid-to Long-term Outcomes After Single Radiofrequency Ablation of Nontoxic and Toxic Thyroid Nodules	47
Association of Thyroid Dysfunction in Individuals ≥ 65 Years of Age With Subclinical Cardiac Abnormalities	47
Approach to the patient: management of bone fragility in patients with chronic hypoparathyroidism	47
Clinical use of Molecular Data in Thyroid Nodules and Cancer	46
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases	46
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy	46
Machine Learning Prediction of Recurrence in Pediatric Thyroid Cancer: Malignant Endocrine Tumors Cohort Analysis Using XGBoost and SHAP	46
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism	46
Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction	46
Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens	46
Association of Age at Menarche With Inflammation and Glucose Metabolism Biomarkers in US Adult Women: NHANES 1999-2018	45
Interim Effects of Zoledronate, Denosumab, or Teriparatide on Bone Microarchitecture in Type 2 Diabetes: A Pilot Trial	45

Correction to “Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study”	45
Remnant Cholesterol Is Associated With Gestational Diabetes Mellitus: A Cohort Study	45
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy	44
Effect of Anamorelin, a Ghrelin Receptor Agonist, on Muscle and Bone in Adults With Osteosarcopenia	44
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman	44
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade	43
Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls	43
High Incidence of Diabetes Mellitus After Distal Pancreatectomy and Its Predictors: A Long-term Follow-up Study	43
Correction to “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline”	42
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose	42
Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study	42
Response to Letter to the Editor From Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	42
Correction to: “Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH”	41
Response to Letter to the Editor from Hao and Xue: “Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”	41
Effects of Rare Coding Variants in Severe Early-Onset Obesity Genes in the Population-Based UK Biobank Study	41
Precision Medicine in Acromegaly: The Potential of Multimodal Therapy	41
New Insights on the Environment of Sex Steroids in Adipose Tissue of Postmenopausal Women at Hormone Therapy	41
What Is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?	41
Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission	40
Correction to: “Approach to the Patient: Reninoma”	39
Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls	39
Response to Letter to the Editor from de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome (PCOS) in Two Independent Cohorts”	38
New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome	37
Metabolic and muscular effects of switching from somatropin to somapacitan in adults with growth hormone deficiency	37
Dyslipidemia Is Associated With Increased Natural Killer Cell Cytotoxicity and Autoimmunity in Women With Recurrent Pregnancy Losses	37
Correction to: “Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy”	37
Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort	37
Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations	36
Association of Glucose Response Shape in OGTT With Markers of Pancreatic Health and Inflammation Across Diverse Ages	36
Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults	36
Higher Plasma Levels of Endocannabinoids and Analogues Correlate With a Worse Cardiometabolic Profile in Young Adults	36
A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma	36
Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance	36
Serum DHEA and Testosterone Levels Associate Inversely With Coronary Artery Calcification in Elderly Men	36
Effects of Puberty Suppression and Sex Steroids on Weight, BMI, and Lipid Profiles in Danish Transgender Adolescents	36
Correction to: “Children With Pancreatic Hypoplasia Experience Poor Weight Gain and Labile Diabetes but Low Incidence of DKA”	36
RETRACTED AND REPLACED: Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles	35
Dose-related Effects of Calcium to Enhance the Effects of L-tryptophan on Gut Hormones and Energy Intake in Obesity	35
RBP4-based Multimarker Score: A Prognostic Tool for Adverse Cardiovascular Events in Acute Coronary Syndrome Patients	35
Associations of Serum 25(OH)D With Risk of Recurrent Cardiovascular Events in Individuals With Coronary Heart Disease	35
Association Between Systemic Lupus Erythematosus and Primary Hypothyroidism: Evidence from Complementary Genetic Methods	35
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience	35
Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas	35
Correction to “Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage”	34
Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices	34
Comparative Efficacy of Radioiodine Therapy With Adjunctive Thionamides vs Either Treatment Alone in the Management of Graves Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Tr	34
Disordered Eating Behaviors During Adolescence and Risk of Polycystic Ovary Syndrome: A Prospective Cohort Study	34
Aggressive Subtypes of Papillary Microcarcinoma	34
Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality	34
Subclinical ocular alterations in Graves' disease: The FUMO score, a new tool to predict Graves' orbitopathy progression	33
Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test	33
Does the Duration of Diabetes Matter When Evaluating the Risk of Heart Failure?	33
Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study	33
Total and Regional Fat-To-Muscle Mass Ratio in Relation to All-Cause and Cause-Specific Mortality in Men and Women	33
Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control	33
Low T3 Syndrome on Admission and Response to Nutritional Support in Malnourished Medical Inpatients	33
Low-Quality Carbohydrate Intake Is Associated With a Higher Prevalence of Metabolic Syndrome: The AWHS Study	33
Mortality risk and causes of death in exogenous Cushing's syndrome: a systematic review and meta-analysis	33
Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes	33
Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study	33
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity	33
IGF-1/IGFBP-3 Serum Ratio as a Robust Measure to Determine GH Deficiency and Guide Human Recombinant GH Therapy	33
Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience	33
Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome	33
Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms	33
A Global Approach to the Long-Term Follow-Up of 17 Families With Bilateral Macronodular Adrenal Disease	33
Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones	33
Back to the Drawing Board: Rethinking Inflammation in Polycystic Ovary Syndrome	33
Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline	33
Sleep Patterns, Plasma Metabolome, and Risk of Incident Type 2 Diabetes Mellitus	32
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management	32
Three-Year Observation of Glucose Metabolism After Pancreaticoduodenectomy: A Single-Center Prospective Study in Japan	32
The Impact of Acute Nutritional Interventions on the Plasma Proteome	32
The Multifaceted Roles of Bone Marrow Adipocytes in Bone and Hematopoietic Homeostasis	32
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine	32
Correction to “Reduced Sensitivity to Thyroid Hormones Is Associated With High Remnant Cholesterol Levels in Chinese Euthyroid Adults”	32
Prevalence of Cortisol Cosecretion in Patients With Primary Aldosteronism: Role of Metanephrine in Adrenal Vein Sampling	32
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study	32
Correction to “β-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT”	32
Correction to “Gut Microbiota Composition and Functionality Are Associated With REM Sleep Duration and Continuous Glucose Levels”	31

Correction to: “Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination”	31
Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture	31
Correction to: “Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer”	31
A Nested Case–Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis	31
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity	30
Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism	30
Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome	30
Trends in Osteoporosis Drug Therapy Receipt Among Commercial and Medicare Advantage Enrollees in the United States, 2011-2022	30
Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma	30
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles	30
Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma	30
Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes	29
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome	29
Hyperglycemia Suppresses Lactate Clearance During Exercise in Type 1 Diabetes	29
Prolonged Hypokalemia and Delayed Diagnosis of Primary Aldosteronism: Clinical Course and Risk Factors	29
Approach to the Patient With Parathyroid Carcinoma	29
Gestational hypothyroidism and pregnancy outcomes following hemithyroidectomy: a nationwide matched cohort study	29
Adrenal Venous Sampling Via an Antecubital Approach in Primary Aldosteronism: A Multicenter Study	29
Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease	29
Letter to the Editor from Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	28
Letter to the Editor From Watts and Leslie: Comparisons Between Different Antiosteoporosis Medications on Postfracture Mortality: A Population-based Study	28
Response to Letter to the Editor From Xu and Yang: “Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study)”	28
Understanding Epigenetic Factors on Adiponectin	28
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity	28
New Hope for a Tumor-Directed Therapy for Cushing Disease	28
Response to Letter to the Editor from Flood and Hackney: Myofibrillar protein synthesis rates do not differ with low and high estradiol concentrations across the menstrual cycle	28
Signs of Glucagon Resistance After a 2-Week Hypercaloric Diet Intervention	28
Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines	28
Diabetes Duration and the Reverse Impact Between Cholesterol Levels and Risk Among Individuals With Type 2 Diabetes	28
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study	27
Genetic Variants Associated With the Biochemical Response to Vitamin D3 in the Multi-Ethnic Study of Atherosclerosis	27
Basal Hyperglycemia Contributes More Than 50% to Time in Range in Pregnant Women With Type 1 Diabetes	27
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome	27
Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality	27
Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study	27
Letter to the Editor From de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts”	27
Sex Hormones Mediate Intensive Lifestyle Intervention–Induced Bone Mineral Density Changes: Look AHEAD Sex Hormone Study	27
It's Not Just About the Hot Flashes: Menopausal Hormone Changes and Disrupted Sleep	27
Serum Concentrations of Inhibin B in Healthy Females and Males Throughout Life	27
Compartment-specific Metabolic Alterations to Insulin Reflect Adiposity-driven Variation and Predict Type 2 Diabetes	27
A Possible New Biomarker for T1D? : RNA Splicing in Circulating Blood	27
Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts	27
New Insights in the Pathophysiology, Epidemiology, and Response to Treatment of Osteoporotic Vertebral Fractures	27
Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary Thyroid Cancer	26
MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics	26
The Association of Female and Male Preconception Dyslipidemia With Live Birth in Couples Seeking Fertility Treatment	26
Skeletal Effects of Sleeve Gastrectomy, by Sex and Menopausal Status and Compared to Roux-En-Y Gastric Bypass Surgery	26
Alteration of Bone Microarchitecture in Hereditary Distal RTA Patients With SLC4A1 Gene Mutation: Assessed by HR-pQCT	26
Maternal Thyroid Function: Does It Have a Role in Fetal Programming and Later Offspring Growth?	26
Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction	26
GH Treatment in Children of Normal Height	26
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)	26
Permanent vs Transient Congenital Hypothyroidism in Chinese Children: Physical Growth and Predictive Nomogram	26
Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men	26
An Interpretable Machine-Learning Model for Predicting Occult Central Lymph Node Metastasis in Papillary Thyroid Cancer	26
Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea	26
Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted	26
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance	26
The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study	26
Letter to the Editor From Tang and Zhang: “Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia”	25
Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN)	25
X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline	25
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France	25
Gonadal Function and Its Evolution in 46,XX Testicular/Ovotesticular DSD	25
Modified-Release Hydrocortisone for Female Fertility in Congenital Adrenal Hyperplasia	25
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline	25
Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy	25
Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent Studies	25
Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy	25
Approach to the Patient: Diagnosis of Cushing Syndrome	25
Novel Cardiometabolic Medications in the Cardiovascular-Kidney-Metabolic Syndrome Era	25
Human GH Use By Athletes With Short Stature Without GH Deficiency: Therapeutic Use Exemptions	25
Inhibiting Soluble Epoxide Hydrolase Suppresses NF-κB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis	25
Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment	25
Metabolic Phenotype of Stage 1 and Stage 2 Type 1 Diabetes Using Modeling of β Cell Function	25
Imminent fracture risk: contributing mechanisms, risk assessment, and implications for treatment	25
Correction to: Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials	25
Shaping the Skeleton: Impact of GnRH Analogue and Sex Hormone Therapy on Skeletal Dimensions in Transgender Individuals	25
Cardiometabolic Risk Assessment in Transgender Individuals—Differential Effect of Sex Hormones and Sex Chromosomes	25
Does metabolically healthy obesity really exist: going toward new definitions	25
Age-Stratified Reference Ranges for Directly Measured Serum Free Testosterone in Community-Dwelling and Healthy Men	25
Correction to: “Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study”	25
Approach to the Patient With a Suboptimal Statin Response: Causes and Algorithm for Clinical Management	24
Effects of 25-Hydroxyvitamin D Levels on Renal Function: A Bidirectional Mendelian Randomization Study	24
Correction to: “Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline”	24
Magnesium Depletion, Metabolic Impairment, and Cardiac Alterations: The NAKO-MRI Study With Mendelian Randomization	24
Cord Blood Fetuin-B, Fetal Growth Factors, and Lipids in Gestational Diabetes Mellitus	24
Changing understanding of acromegaly epidemiology and early mortality risk	24
Visceral adipose tissue and liver fat on 17-beta estradiol-dominant gender-affirming hormone therapy: A US-based cohort	24
Correction to: “Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline”	24
Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome	24
Impaired Adipocyte SLC7A10 Promotes Lipid Storage in Association With Insulin Resistance and Altered BCAA Metabolism	24
Impact of Distinct Antiandrogen Exposures on the Plasma Metabolome in Feminizing Gender-affirming Hormone Therapy	24
Approach to the patient: genetics and management of congenital hypothyroidism	24
Polygenic Scores for Adult Testosterone and SHBG Levels Are Associated With Reproductive Hormone Levels in Male Infants	24